ÔçÒÒŮѸÀ×

    1. <form id=SSjMaZxIp><nobr id=SSjMaZxIp></nobr></form>
      <address id=SSjMaZxIp><nobr id=SSjMaZxIp><nobr id=SSjMaZxIp></nobr></nobr></address>

      Current Value of Holding

      $149M

      Shares

      33M

      % of Portfolio

      1.09%

      Average Buy Price

      $9.64

      Avg closing price
      Price range

      17 Cathie Wood Recursion Pharmaceuticals Trades

      Cathie Wood acquired 33M Recursion Pharmaceuticals shares worth $149M. That's 1.09% of their equity portfolio (27th largest holding). The investor owns 7.42% of the outstanding Recursion Pharmaceuticals stock. The first Recursion Pharmaceuticals trade was made in Q2 2021. Since then Cathie Wood bought shares eleven more times and sold shares on five occasions. The investor's estimated purchase price is $318M, resulting in a loss of 53%.

      Avg closing price
      Price range
      Sold 5.2% shares (-1.83M shares) Q2 2025
      Avg closing price $4.91
      Price range $3.97 - $5.84
      Increased shares by 7.6% (+2.47M shares) Q1 2025
      Avg closing price $7.33
      Price range $5.29 - $10.87
      Sold 1.3% shares (-423k shares) Q4 2024
      Avg closing price $6.72
      Price range $5.70 - $8.27
      Increased shares by 16.4% (+4.63M shares) Q3 2024
      Avg closing price $7.17
      Price range $5.92 - $8.60
      Increased shares by 14.5% (+3.56M shares) Q2 2024
      Avg closing price $8.72
      Price range $7.35 - $10.05
      Increased shares by 19.0% (+3.93M shares) Q1 2024
      Avg closing price $11.14
      Price range $9.13 - $15.52
      Increased shares by 200.4% (+13.8M shares) Q4 2023
      Avg closing price $7.13
      Price range $5.09 - $10.79
      Increased shares by 45.1% (+2.14M shares) Q3 2023
      Avg closing price $9.98
      Price range $6.59 - $15.86
      Increased shares by 32.5% (+1.16M shares) Q2 2023
      Avg closing price $7.00
      Price range $4.56 - $9.94
      Increased shares by 15.4% (+477k shares) Q1 2023
      Avg closing price $7.93
      Price range $6.42 - $9.64
      Sold 7.7% shares (-260k shares) Q4 2022
      Avg closing price $9.81
      Price range $7.16 - $12.70
      Increased shares by 23.0% (+628k shares) Q3 2022
      Avg closing price $10.13
      Price range $7.83 - $13.60
      Sold 3.4% shares (-95.1k shares) Q2 2022
      Avg closing price $6.69
      Price range $5.04 - $9.26
      Increased shares by 26.7% (+595k shares) Q1 2022
      Avg closing price $10.63
      Price range $6.16 - $18.03
      Sold 13.9% shares (-362k shares) Q4 2021
      Avg closing price $18.82
      Price range $16.14 - $21.86
      Increased shares by 9.0% (+215k shares) Q3 2021
      Avg closing price $28.34
      Price range $19.03 - $41.33
      New holding (+2.38M shares) Q2 2021
      Avg closing price $29.60
      Price range $21.06 - $37.42

      News about Recursion Pharmaceuticals Inc - Ordinary Shares - Class A and Cathie Wood

      Cathie Wood Is Betting Big on Recursion Pharmaceuticals (RXRX) Stock

      Cathie Wood Is Betting Big on Recursion Pharmaceuticals (RXRX) Stock

      Recursion Pharmaceuticals (NASDAQ: RXRX ) is one of the high-flying stocks gaining focus in today¡¯s market. Indeed, shares of RXRX stock are rocketing more t...

      InvestorPlace InvestorPlace, over 1 year ago
      Cathie Wood Just Made a Big Bet on Recursion Pharmaceuticals Stock. Will It Pay Off?

      Cathie Wood Just Made a Big Bet on Recursion Pharmaceuticals Stock. Will It Pay Off?

      Cathie Wood just gave the company a huge vote of confidence.

      The Motley Fool The Motley Fool, almost 2 years ago

      Embed chart

      Easily embed the chart on your blog or website ¨C it will always update automatically!

      HoMEÔçÒÒŮѸÀ×